Julia Reda-Led Panel Discussion Reveals – Publishers’ Right Faces High Resistance From Academic Circles 21/01/2018 by Intellectual Property Watch 2 Comments The Greens/EFA Group in the European Parliament organised last autumn the panel discussion titled, “Better Regulation for Copyright: Academics Meet Policy Makers” in Brussels. This is an initiative that together with a recently published study questions whether national and EU neighbouring rights for publishers are actually lawful. The article below gives an overview of the panel discussion and movements that followed in the legislative process in Brussels, with a special focus on the press publishers right, writes Ines Duhanic.
Moving Landscape In The IP World – Organisations, Industry, Law Firms 19/01/2018 by Catherine Saez, Intellectual Property Watch 1 Comment The end of 2017 and start of 2018 brought a lot of changes in the global intellectual property arena. The World Health Organization underwent major changes in its leadership following a new head elected in May, UNAIDS has a new deputy executive director, the World Intellectual Property Organization is seeking a new leader of its Global Challenges division, and the Board of the Internet Corporation for Assigned Names and Numbers decided on a number of appointments. The European Patent Office elected a new president, and the industry world also saw its share of changes. The International Federation of Pharmaceutical Manufacturers and Associations welcomed some new faces, and the head of the Federation of the European Sporting Goods Industry is changing. Law firms saw a high level of revolving chair movements, and promotions of attorneys to partners.
EPO-EU Conference Examines Hot Topic Of Patentability Of Plants In Europe 18/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The last couple of years have brought heated discussions in Europe on the patentability of plant innovations, leading to a recent amendment of patent application rules at the European Patent Office. Two major actors share this innovation landscape: the biotechnologists and the plant breeders, with similar but not identical needs for protecting their invention. A joint conference on innovation in the plant sector was held recently by the EPO and the Community Plant Variety Office.
Industry Alliance Report: Companies Invest In AMR R&D, Need More Pull Incentives 18/01/2018 by Intellectual Property Watch 1 Comment An alliance of over a hundred industries seeking to curb antimicrobial resistance launched its first report today. According to the report, a number of companies are heavily investing in research and development, and work to improve access to their diagnostic products and preventing therapies.
Year Ahead: Copyright, Unified Patent Court Remain High On EU Priority List 16/01/2018 by Dugie Standeford for Intellectual Property Watch 3 Comments Plans to update European Union copyright rules advanced in 2017 but remain contentious heading into the new year. The proposal for a directive on copyright in the digital single market is the subject of intense debate between the EU Presidency and the European Parliament, with no clear end in sight to the negotiations. Several issues, including a possible “ancillary right” for news publishers and a plan to force online platforms to filter all uploads to combat copyright infringement, remain unresolved. Other copyright matters, such as a regulation on broadcasting and a review of the EU database directive, are in the works. On the patent side, a pressing question is whether – and when – the EU unified patent and patent court (UPC) might finally launch. Several EU comprehensive trade agreements, which include provisions on intellectual property rights, are under negotiation. Cases to watch in the European Court of Justice include a referral from the Netherlands on the issue of whether the taste of cheese can be copyrighted.
Libraries – A Trio Of European Court Rulings 16/01/2018 by Intellectual Property Watch Leave a Comment In recent years, the Court of Justice of the European Union (CJEU), Europe’s highest court, has made three important rulings concerning digital library activities in Europe, Vincent Bonnet and Barbara Stratton write on the EIFL blog.
Internet Content Control Is Here, UN Special Rapporteur Warns IGF 19/12/2017 by Monika Ermert for Intellectual Property Watch 1 Comment “Internet content regulation is coming, in fact it is already here,” said David Kaye, United Nations special rapporteur on the promotion and protection of the right to freedom of opinion and expression, during a panel organised by the Global Network Initiative on day one of the 12th Internet Governance Forum in Geneva this week.
G-Finder Report: Global Funding For R&D In Neglected Diseases Increasing, Overreliance On US Funding Dangerous 13/12/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment A report released today on global funding of research and development for neglected diseases found that global funding has increased but warns that overreliance on funding from the United States, which the report says is “unparalleled,” and leads to a heavy concentration of global funding on HIV/AIDS, malaria and tuberculosis. This overreliance could also lead to change in total global funding, the report found.
European Parliament Wants To Write The Rules For Digital Trade 12/12/2017 by Monika Ermert for Intellectual Property Watch Leave a Comment The European Parliament today adopted a report that lays out a European digital trade strategy. Adopted by a margin of 510 to 95 in Strasbourg, the report obliges the Commission to make digital trade an essential part in the European trade policy.
Medicines Patent Pool Expands Its Patent Database To Cancer Treatments 12/12/2017 by Intellectual Property Watch Leave a Comment The Medicines Patent Pool (MPP) announced today that MedsPaL, its database of information on the patent and licensing status of selected HIV, hepatitis C, and tuberculosis medicines, now extends to patented treatments on the World Health Organization Model List of Essential Medicines. New patents data include medicines for leukaemia, breast cancer and other cancer indications.